Clinical Trial Update: Pola-ZR2P in Previously Untreated DLBCL [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of Pola-ZR2P for previously untreated diffuse large B-cell lymphoma, currently recruiting. Sponsor: Navy Gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Pola-ZR2P

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: RECRUITING